SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Mar 30, 17:00
3426.40
11.65 (0.34%)
VOLUME 7,100
LIVE
NSE
Mar 30, 17:00
3425.30
9.9 (0.29%)
VOLUME 281,925
Announcements on Dr Reddys Labs

30th-Mar-2015 15:27Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Amit Parekh has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

27th-Mar-2015 17:10Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Swaminathan Chandrasekaran & Abhijit Mukherjee has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

25th-Mar-2015 19:41Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Dr Reddys Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

23rd-Mar-2015 16:21Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy''s Laboratories Limited has informed the Exchange regarding a press release dated March 23, 2015, titled "Dr. Reddy s Laboratories enters into partnership with Hetero to accelerate access to...

23rd-Mar-2015 16:11Source: BSE

Dr Reddys Labs- Dr. Reddy’s Laboratories enters into partnership with Hetero to accelerate access to treatment for Hepatitis C in India

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated March 23, 2015 titled "Dr. Reddy’s Laboratories enters into partnership with Hetero to accelerate access to treatment for ...

20th-Mar-2015 19:08Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Dr Reddys Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

20th-Mar-2015 16:10Source: BSE

Dr Reddys Labs- Allotment of Equity Shares on exercise of ESOP

Dr Reddys Laboratories Ltd has informed BSE that pursuant to Dr. Reddy''s Employees Stock Option Scheme, 2002, the Nomination, Governance & Compensation Committee of the Board of Directors of the Comp...

17th-Mar-2015 17:27Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Dr Reddys Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

17th-Mar-2015 12:41Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Sunil Menon has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

16th-Mar-2015 14:19Source: BSE

Dr Reddys Labs- Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

V Viswanath has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

1 2 3 4 5 Next >>
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.